GREAT POINT PARTNERS LLC
CIK 1281446 · last filed 2015-03-18
GREAT POINT PARTNERS LLC is a corporate insider who has filed 20 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for BVX, was dated Mar 18, 2015. Across all open-market trades the lifetime net is −$34.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $86.6M across reported positions. The firm reports its address in Greenwich, CT. 56 SEC filings were submitted jointly with JEFFREY R JAY.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$86.59M
5
20
-$34.53M
Filer Profile
GREENWICH, CT 06830
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apyx Medical Corp (BVX) Delisted | 480,000 | — | — | $0 | 2 | 2015-03-18 | |
| CONNECTURE INC (CNXR) Delisted | 10%+ Owner | 5,898,851 | — | — | -$19.00M | 1 | 2014-12-17 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | Director | 36,414 | — | — | -$1.59M | 9 | 2010-01-13 |
| MEMY | 10%+ Owner | 5,330,339 | $16.24 | $86.59M | -$6.63M | 3 | 2007-11-06 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | 10%+ Owner | 2,216,700 | — | — | -$7.31M | 1 | 2007-01-18 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-03-18 | Apyx Medical Corp (BVX) Delisted | Mixed | +960,000 | $2.40M | EDGAR |
| 2014-12-17 | CONNECTURE INC (CNXR) Delisted | Mixed | +33,017,790 | -$19.00M | EDGAR |
| 2014-09-15 | Apyx Medical Corp (BVX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-11-19 | — | Conv (C) | +1,799,786 | $0 | |
| 2013-08-29 | — | Mixed | — | $0 | |
| 2013-04-03 | — | Grant (A) | — | $0 | |
| 2010-01-13 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −138,420 | -$696.9K | EDGAR |
| 2009-10-19 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −29,200 | -$147.6K | EDGAR |
| 2009-10-15 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −33,800 | -$176.5K | EDGAR |
| 2009-10-13 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −26,926 | -$139.9K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.